HEDGEHOG INHIBITOR

Clinical trials for HEDGEHOG INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new HEDGEHOG INHIBITOR trials appear

Sign up with your email to follow new studies for HEDGEHOG INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for tough ovarian cancers: testing a powerful drug duo

Disease control Recruiting now

This study is testing a new combination of two drugs, vismodegib and atezolizumab, for women with ovarian, fallopian tube, or primary peritoneal cancer that has become resistant to platinum-based chemotherapy. The goal is to see if this drug pair can shrink tumors and control the…

Matched conditions: HEDGEHOG INHIBITOR

Phase: PHASE2 • Sponsor: Ronald Buckanovich • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

HEDGEHOG INHIBITOR

Get alerted when new HEDGEHOG INHIBITOR trials appear

New hope for tough ovarian cancers: testing a powerful drug duo